ETR:RHK RHÖN-KLINIKUM Aktiengesellschaft (RHK) Stock Price, News & Analysis €11.60 -0.10 (-0.85%) As of 09/15/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesBuy This Stock About RHÖN-KLINIKUM Aktiengesellschaft Stock (ETR:RHK) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get RHK alerts:Sign Up Key Stats Today's Range€11.60▼€11.6050-Day Range€11.30▼€12.1052-Week Range€9.50▼€14.00Volume424 shsAverage Volume43,281 shsMarket Capitalization€770.98 millionP/E Ratio17.18Dividend Yield1.29%Price TargetN/AConsensus RatingN/A Company Overview RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany. Read More Receive RHK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RHÖN-KLINIKUM Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RHK Stock News HeadlinesZukunft des UKGM: Rhön-Klinikum stellt Einigung infrageMay 11, 2022 | finanznachrichten.deRhön-Klinikum kommt gut durchs Corona-Jahr 2021March 25, 2022 | finanznachrichten.deReagan’s former tech advisor sharing bombshell announcementGeorge Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the last 40 years. Now he's stepping forward with an even bigger prediction about what's being built in the Arizona desert. He believes 3 little-known companies will explode when a bombshell announcement just days from now. Smart investors are already positioning themselves.September 16 at 2:00 AM | Banyan Hill Publishing (Ad)RHÖN-KLINIKUM AG looks back on successful financial year 2021March 25, 2022 | uk.finance.yahoo.comWarum Technik und Medizin gut zusammenpassen - RHÖN fördert praxisorientierte Studien- und BerufsorientierungFebruary 19, 2022 | finanznachrichten.deRHÖN-KLINIKUM Campus Bad Neustadt ist TAVI-ZentrumFebruary 19, 2022 | finanznachrichten.deSee More Headlines RHK Stock Analysis - Frequently Asked Questions How have RHK shares performed this year? RHÖN-KLINIKUM Aktiengesellschaft's stock was trading at €13.90 at the beginning of 2025. Since then, RHK shares have decreased by 16.5% and is now trading at €11.60. What other stocks do shareholders of RHÖN-KLINIKUM Aktiengesellschaft own? Based on aggregate information from My MarketBeat watchlists, some other companies that RHÖN-KLINIKUM Aktiengesellschaft investors own include Seabridge Gold (SA), Walt Disney (DIS), iShares Silver Trust (SLV), Alamos Gold (AGI), Anheuser-Busch InBev SA/NV (BUD) and Gilead Sciences (GILD). Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolETR:RHK CIKN/A Webwww.rhoen-klinikum-ag.com Phone+49-9-771650FaxN/AEmployees18,324Year FoundedN/AProfitability EPS (Trailing Twelve Months)€0.68 Trailing P/E Ratio17.18 Forward P/E Ratio38.99 P/E Growth26.77Net Income€44.55 million Net Margins2.90% Pretax MarginN/A Return on Equity3.54% Return on Assets1.59% Debt Debt-to-Equity RatioN/A Current Ratio2.35 Quick Ratio2.12 Sales & Book Value Annual Sales€1.54 billion Price / Sales0.50 Cash Flow€4.22 per share Price / Cash Flow2.75 Book Value€19.58 per share Price / Book0.59Miscellaneous Outstanding Shares66,463,759Free FloatN/AMarket Cap€770.98 million OptionableNot Optionable Beta-0.13 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (ETR:RHK) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RHÖN-KLINIKUM Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Share RHÖN-KLINIKUM Aktiengesellschaft With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.